Literature DB >> 6181759

Antigenic properties of some equine influenza viruses.

R Burrows, M Denyer.   

Abstract

The antigenic relationships between the haemagglutinins of five A/equine-1 viruses and between six A/equine-2 viruses were examined using post-infection ferret and immunized pony sera. Similar results were obtained with sera from both species for the A/equine-1 viruses and these confirmed minor antigenic differences between the prototype A/Prague 1/56 virus and viruses isolated in England in 1973 and 1977. Considerable antigenic differences were found between five of the A/equine-2 viruses, using ferret sera, but these differences were less evident using pony sera. The response of ponies to the inactivated viruses indicated that there was little need to change the virus strains used in the manufacture of commercial equine influenza vaccines.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6181759     DOI: 10.1007/bf01341723

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  14 in total

1.  A COMPLEMENT FIXATION TECHNIQUE FOR THE QUANTITATIVE MEASUREMENT OF ANTIGENIC DIFFERENCES BETWEEN STRAINS OF THE VIRUS OF FOOT-AND-MOUTH DISEASE.

Authors:  J DAVIE
Journal:  J Hyg (Lond)       Date:  1964-12

2.  The outbreak of equine influenza in England April-May 1973.

Authors:  D G Powell; G R Thomson; P Spooner; W Plowright; R Burrows; G C Schild
Journal:  Vet Rec       Date:  1974-03-30       Impact factor: 2.695

3.  Strain specificity of serum antibody to the haemagglutinin of influenza A (H3N2) viruses in children following immunization or natural infection.

Authors:  J S Oxford; L R Haaheim; A Slepushkin; J Werner; E Kuwert; G C Schild
Journal:  J Hyg (Lond)       Date:  1981-02

4.  A three-year evaluation of four commercial equine influenza vaccines in ponies maintained in isolation.

Authors:  R Burrows; P R Spooner; D Goodridge
Journal:  Dev Biol Stand       Date:  1977 Jun 1-3

5.  Experience of the efficacy of equine influenza vaccinations.

Authors:  T Estola; E Neuvonen
Journal:  Nord Vet Med       Date:  1976 Jul-Aug

6.  Equine influenza in the Netherlands during the winter of 1978-1979; antigenic drift of the A-equi 2 virus.

Authors:  J T van Oirschot; N Masurel; A D Huffels; W J Anker
Journal:  Vet Q       Date:  1981-04       Impact factor: 3.320

7.  A revision of the system of nomenclature for influenza viruses: a WHO memorandum.

Authors: 
Journal:  Bull World Health Organ       Date:  1980       Impact factor: 9.408

8.  Field and laboratory studies of equine influenza viruses isolated in 1979.

Authors:  R Burrows; M Denyer; D Goodridge; F Hamilton
Journal:  Vet Rec       Date:  1981-10-17       Impact factor: 2.695

9.  Persistent antigenic variation of influenza A viruses after incomplete neutralization in ovo with heterologous immune serum.

Authors:  I ARCHETTI; F L HORSFALL
Journal:  J Exp Med       Date:  1950-11-01       Impact factor: 14.307

10.  Australian infectious bronchitis viruses: identification of nine subtypes by a neutralisation test.

Authors:  C N Wadey; J T Faragher
Journal:  Res Vet Sci       Date:  1981-01       Impact factor: 2.534

View more
  4 in total

1.  Development of an enzyme-linked immunosorbent assay (ELISA) for the detection of specific antibodies against an H7N7 and an H3N8 equine influenza virus.

Authors:  M S Denyer; J R Crowther; R C Wardley; R Burrows
Journal:  J Hyg (Lond)       Date:  1984-12

2.  Studies with inactivated equine influenza vaccine. 2. Protection against experimental infection with influenza virus A/equine/Newmarket/79 (H3N8).

Authors:  J Mumford; J M Wood; A M Scott; C Folkers; G C Schild
Journal:  J Hyg (Lond)       Date:  1983-06

3.  Genetic and antigenic analysis of an equine influenza H 3 isolate from the 1989 epidemic.

Authors:  M M Binns; J M Daly; E D Chirnside; J A Mumford; J M Wood; C M Richards; R S Daniels
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

Review 4.  A Systematic Review of Recent Advances in Equine Influenza Vaccination.

Authors:  Romain Paillot
Journal:  Vaccines (Basel)       Date:  2014-11-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.